Several India-listed companies announced key corporate developments ranging from board meetings and earnings disclosures to share allotments, keeping stocks across chemicals, fashion, pharma, and e-commerce segments in focus.
Stallion India Fluorochemicals Ltd informed that its Board of Directors will meet on January 29, 2026, to consider and approve the unaudited financial results for Q3 FY26 and the nine months ended December 31, 2025.
Meesho Limited will host an Investors/Analysts Conference Call on Friday, January 30, 2026, at 6:30 pm IST, to discuss its Q3 FY26 performance. The virtual event details, including the registration link, have been made available on the company’s website. This follows an earlier intimation regarding a board meeting scheduled on the same date.
Novyra Pharmachem Limited announced its unaudited financial results for Q3 FY26 and 9M FY26 on January 26, 2026. The company reported a net loss of ₹1.15 crore in Q3 FY26, compared with a net profit of ₹1.13 crore in Q3 FY25. For the nine-month period, Novyra posted a net loss of ₹1.82 crore, narrowing from a loss of ₹6.36 crore in 9M FY25. Basic and diluted EPS for Q3 FY26 stood at ₹(0.02) versus ₹0.02 in the year-ago quarter.
Go Fashion (India) Limited announced a revised board meeting date of January 29, 2026, to approve its unaudited financial results for Q3 FY26. The board will also consider a proposal for the buy-back of equity shares, a move closely tracked by investors.
Meanwhile, Vaxfab Enterprises Ltd disclosed that it has rectified typographical errors in earlier communications related to warrant conversions and has approved the allotment of 34,39,136 equity shares at ₹21.02 per share upon conversion of warrants on a preferential basis. Post allotment, the company’s paid-up equity share capital stands at ₹16.05 crore, comprising 1,60,49,489 equity shares, with the newly issued shares ranking pari passu with existing equity shares.
